Thrombotic microangiopathy after living-donor liver transplantation

American Journal of Transplantation

Volumn 12, Issue 3, 2012, Pages 728-736

  Shindoh, J ^a   Sugawara, Y ^a   Akamatsu, N ^b   Kaneko, J ^a   Tamura, S ^a   Yamashiki, N ^c   Aoki, T ^a   Sakamoto, Y ^a   Hasegawa, K ^a   Kokudo, N ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b SAITAMA MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Hemolytic uremic syndrome; liver transplantation; living donor; thrombotic microangiopathy

Indexed keywords

BASILIXIMAB; CYCLOSPORIN; FRESH FROZEN PLASMA; HLA ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTINUOUS INFUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; FEMALE; HEMOLYTIC UREMIC SYNDROME; HLA SYSTEM; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; END STAGE LIVER DISEASE; FEMALE; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; THROMBOTIC MICROANGIOPATHIES; YOUNG ADULT;

EID: 84857656226     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03841.x     Document Type: Article

References (43)

1. Moake JL,. Thrombotic microangiopathies. N Engl J Med 2002; 347: 589-600.
2. Humar A, Jessurun J, Sharp HL, Gruessner RW,. Hemolytic uremic syndrome in small-bowel transplant recipients; the first two case reports. Transpl Int 1999; 12: 387-390. (Pubitemid 29502011)
3. Trimarchi HM, Truong LD, Brennan S, Gonzalez JM, Suki WN,. FK506-associated thrombotic microangiopathy; report of two cases and review of the literature. Transplantation 1999; 67: 539-544. (Pubitemid 29114215)
4. Miyata R, Shimazu M, Tanabe M, et al,. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation. Liver Transpl 2007; 13: 1455-1462. (Pubitemid 47629581)
5. Tamura S, Sugawara Y, Matsui Y, et al,. Thrombotic microangiopathy in living-donor liver transplantation. Liver Transpl 2005; 80: 169-175. (Pubitemid 41061672)
6. Noris M, Remuzzi G,. Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517-1523.
7. Schwarz A, Haller H, Schmitt R, et al,. Biopsy-diagnosed renal disease in patients after transplantation of other organs and tissues. Am J Transpl 2010; 10: 2017-2025.
8. Nishi H, Hanafusa N, Kondo Y, et al,. Clinical outcome of thrombotic microangiopathy after living-donor liver transplantation treated with plasma exchange therapy. Clin J Am Soc Nephrol 2006; 1: 811-819.
9. Sugawara Y, Makuuchi M,. Technical advances in living-related liver transplantation. J Hepatobiliary Pancreat Surg 1999; 6: 245-253.
10. Sugawara Y, Makuuchi M,. Right lateral sector graft as a feasible option for partial liver transplantation. Liver Transpl 2004; 10: 1156-1157. (Pubitemid 39248414)
11. Sugawara Y, Makuuchi M,. Advances in adult living donor liver transplantation: A review based on reports from the 10th anniversary of the adult-to-adult living donor liver transplantation meeting in Tokyo. Liver Transpl 2004; 10: 715-720. (Pubitemid 38787127)
12. Sugawara Y, Makuuchi M, Akamatsu N, et al,. Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl 2004; 10: 541-547. (Pubitemid 38443594)
13. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M,. Sling suspension of the liver in donor operation: A gradual tape-repositioning technique. Transplantation 2003; 76: 803-807. (Pubitemid 37140223)
14. Kokudo N, Sugawara Y, Kaneko J, Imamura H, Sano K, Makuuchi M,. Reconstruction of isolated caudate portal vein in left liver graft. Liver Transpl 2004; 10: 1163-1165. (Pubitemid 39248416)
15. Sugawara Y, Makuuchi M, Kaneko J, Ohkubo T, Imamura H, Kawarasaki H,. Correlation between optimal tacrolimus doses and the graft weight in living donor liver transplantation. Clin Transplant 2002; 16: 102-106. (Pubitemid 34414057)
16. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M,. Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplantation 2005; 5: 1694-703. (Pubitemid 40910452)
17. Zeigler ZR, Shadduck RK, Nemunaitis J, Andrews DF, Rosenfeld CS,. Bone marrow transplant-associated thrombotic microangiopathy: A case series. Bone Marrow Transplant 1995; 15: 247-253.
18. Tamura S, Sugawara Y, Kishi Y, et al,. Conversion to cyclosporine provides valuable rescue therapy for living related adult liver transplantation intolerant of tacrolimus: A single center experience at the University of Tokyo. Transplant Proc 2004; 36: 3242-3344.
19. Akamatsu N, Sugawara Y, Tamura S, Imamura H, Kokudo N, Makuuchi M,. Regeneration and function of hemiliver graft: Right versus left. Surgery 2006; 139: 765-772. (Pubitemid 43902911)
20. Ponticelli C, Banfi G,. Thrombotic microangiopathy after kidney transplantation. Transplant Int 2006; 19: 789-794. (Pubitemid 44358844)
21. Burke GW, Ciancio G, Cirocco R, et al,. Microangiopathy in kidney and simultaneous pancreas/kidney recipients treated with tacrolimus: Evidence of endothelin and cytokine involvement. Transplantation 1999; 68: 1336-1342.
22. Noris M, Remuzzi G,. Thrombotic microangiopathy after kidney transplantation. Am J Transplant 2010; 10: 1517-1523.
23. Tsai HM, Lian EC,. Antibodies to von Willebrand factor-Cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 1998; 339: 1585-1594. (Pubitemid 28536133)
24. Furlan M, Robles R, Galbusera M, et al,. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolyticuremic syndrome. N Engl J Med 1998; 339: 1578-1584. (Pubitemid 28536132)
25. Nakazawa Y, Hashikura Y, et al,. Von Willebrand factor- Cleaving protease activity in thrombotic microangiopathy after living donor liver transplantation: A case report. Liver Transpl 2003; 9: 1328-1333. (Pubitemid 37536804)
26. Kobayashi T, Wada H, Usui M, et al,. Decreased ADAMTS13 levels in patients after living donor liver transplantation. Thromb Res 2009; 124: 541-545.
27. Furlan M, Lammle B,. Haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura: New insights into underlying biochemical mechanisms. Nephrol Dial Transplant 2000; 15: 1112-1114. (Pubitemid 30487782)
28. Allford SL, Machin SJ,. Current understanding of the pathophysiology of thrombotic thrombocytopenic purpura. J Clin Pathol 2000; 53: 497-501. (Pubitemid 30432105)
29. Bonser RS, Adu D, Franklin I, McMaster P,. Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient. Lancet 1984; 2: 1337. (Pubitemid 15176818)
30. Dzik WH, Georgi BA, Khettry U, Jenkins RL,. Cyclosporine-associated thrombotic thrombocytopenic purpura following liver transplantation: Successful treatment with plasma exchange. Transplantation 1987; 44: 570-572.
31. McCauley J, Bronsther O, Fung J, Todo S, Starzl TE,. Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. Lancet 1989; 2 (8678-8679): 1516. (Pubitemid 20018156)
32. Holman MJ, Gonwa TA, Cooper B, et al,. FK506-associated thrombotic thrombocytopenic purpura. Transplantation 1993; 55: 205-206. (Pubitemid 23033973)
33. Hochstetler LA, Flanigan MJ, Lager DJ,. Transplant-associated thrombotic microangiopathy: The role of IgG administration as initial therapy. Am J Kidney Dis 1994; 23: 444-450. (Pubitemid 24081386)
34. Mach-Pascual S, Samii K, Beris P,. Microangiopathic hemolytic anemia complicating FK506 (tacrolimus) therapy. AmJ Hematol 1996; 52: 310-312. (Pubitemid 26288744)
35. Singh N, Gayowski T, Marino IR,. Hemolytic uremic syndrome in solid-organ transplant recipients. Transpl Int 1996; 9: 68-75. (Pubitemid 126509976)
36. Hod E, Schwartz J,. Platelet transfusion refractoriness. Br J Haematol 2008; 142: 348-360. (Pubitemid 351962170)
37. Feucht HE, Schneeberger H, Hillebrand G, et al,. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int 1993; 43: 1333-1338. (Pubitemid 23161421)
38. McKenna RM, Takemoto SK, Terasaki PI,. Anti-HLA antibodies after solid organ transplantation. Transplantation 2000; 69: 319-326. (Pubitemid 30118107)
39. Terasaki PI,. Humoral theory of transplantation. Am J Transplant 2003; 3: 665-673. (Pubitemid 36745238)
40. Takemoto SK, Zeevi A, Feng S, et al,. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004; 4: 1033-1041. (Pubitemid 38868592)
41. Ionescu DN, Girnita AL, Zeevi A, et al,. C4d deposition in lung allografts is associated with circulating anti-HLA alloantibody. Transpl Immunol 2005; 15: 63-68. (Pubitemid 41434009)
42. Girnita AL, Webber SA, Zeevi A,. Anti-HLA alloantibodies in pediatric solid organ transplantation. Pediatr Transplant 2006; 10: 146-153.
43. Nashan B, Moore R, Amlot P, Schmidt AG, Abeywickrama K, Soulillou JP,. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group. Lancet 1997; 350: 1193-1198. (Pubitemid 127445091)